News
FDA Commissioner Marty Makary announced Thursday that the agency will soon provide clear guidelines to vaccine manufacturers ...
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...
The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
1d
MedPage Today on MSNFDA Officials Detail Plan to Limit COVID ShotsThe FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...
FDA Commissioner Dr. Marty Makary and vaccine chief Dr. Vinay Prasad set stricter approval standards for booster shots ...
The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for certain ...
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...
Before being confirmed as the head of the U.S. Food and Drug Administration (FDA) on March 25, Dr. Marty Makary was an ...
The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results